CVE-2025-46254: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Visual C
CVE-2025-46254 is a medium-severity flaw (CVSS 6.5) affecting visual composer website builder. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Visual Composer Visual Composer Website Builder visualcomposer allows Stored XSS.This issue affects Visual Composer Website Builder: from n/a through <= 45.10.0.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 6.5 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | Required |
| EPSS exploit chance | 0.2% (top 87%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2025-04-22 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2025-46254?
visual composer website builder: upgrade to 45.11.0. Exact commands for each OS are on this page.
Is CVE-2025-46254 being exploited?
CVE-2025-46254 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2025-46254 affect?
CVE-2025-46254 affects visual composer website builder. Severity is medium (CVSS 6.5). Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Visual Composer Visual Composer Website Builder visualcomposer allows Stored XSS.This issue affects Visual Composer Website Builder: from
How urgent is CVE-2025-46254?
Priority 26/100. No elevated risk signals yet.